Go Unlimited with Magzter GOLD
Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just
Try GOLD - Free
Netflix to go all cash for Warner Bros
Mint Mumbai
|January 21, 2026
Netflix has switched to an all-cash offer for Warner Bros Discovery's studio and streaming assets without increasing the $82.7 billion price in a bid to shut the door on Paramount's rival efforts to snag the Hollywood giant.
The new all-cash bid—at $27.75 a share—has unanimous support from the HBO owner's board, according to a Tuesday regulatory filing. Both Netflix and Paramount Skydance cov
This story is from the January 21, 2026 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
BUDGET TO KEEP FISC STEADY AMID GLOBAL STORM
The Union Budget for FY27 is being formulated against the backdrop of some positive surprises, despite a highly volatile and uncertain global environment.
3 mins
January 23, 2026
Mint Mumbai
Govt may raise allocation for power distribution reforms
Revamped Distribution Sector Scheme is likely to get ₹18,000 crore in the FY27 budget
2 mins
January 23, 2026
Mint Mumbai
Pet care startups eye users to compete with FMCG giants
Direct-to-consumer (D2C) pet care brands are leaning on subscription models to lock in customers, betting that repeat purchases can help them counter the scale and distribution advantage of India's largest packaged consumer goods players as the niche segment heats up.
2 mins
January 23, 2026
Mint Mumbai
IT majors face weak FY26 despite Q3 earnings beats
Four top IT services firms are heading into Q4 with weaker full-year trajectories than last year
3 mins
January 23, 2026
Mint Mumbai
Here's how to build an education fund in a high-inflation economy
With education inflation running at 10-12% annually, far outpacing CPI, parents must rethink savings strategies
4 mins
January 23, 2026
Mint Mumbai
Zydus launches cancer biosimilar
Zydus Lifesciences has launched its biosimilar of anticancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the patented version.
1 min
January 23, 2026
Mint Mumbai
AI accessibility: We need to clearly define what it means
As the world approaches the India AI Summit 2026 , the conversation on AI has evolved beyond algorithmic efficiency to encompass the more significant issues of digital sovereignty and ethics.
3 mins
January 23, 2026
Mint Mumbai
Retail boosts IPO odds via parent shares
A smart move? Investors are reviving an old strategy by buying parent shares ahead of subsidiary IPOs.
3 mins
January 23, 2026
Mint Mumbai
Behind Kalyan Jewellers’ stock slump
Kalyan Jewellers has had a rough start to 2026, with the stock sliding around 22% this calendar year, lagging peers.
3 mins
January 23, 2026
Mint Mumbai
Family-run Duroflex gears up for IPO
After more than six decades as a privately held, family-run business, mattress maker Duroflex believes it is ready for the public markets, top executives of the company told Mint.
2 mins
January 23, 2026
Listen
Translate
Change font size